Pdt Partners, LLC Amphastar Pharmaceuticals, Inc. Transaction History
Pdt Partners, LLC
- $1.02 Billion
- Q3 2024
A detailed history of Pdt Partners, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 81,184 shares of AMPH stock, worth $2.9 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
81,184
Previous 9,702
736.78%
Holding current value
$2.9 Million
Previous $388,000
915.21%
% of portfolio
0.38%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding AMPH
# of Institutions
284Shares Held
34.8MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$212 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$96.7 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$76.1 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$69.4 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$57.6 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.75B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...